Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial deoxyguanosine kinase (dGK) is an enzyme encoded by the DGUOK gene. It is a nucleoside kinase located in the mitochondrial matrix and plays a critical role in the salvage pathway of purine deoxynucleotide biogenesis within mitochondria. dGK catalyzes the phosphorylation of purine deoxyribonucleosides, specifically deoxyguanosine and deoxyadenosine, to their corresponding monophosphate forms, which is essential for mtDNA replication and repair. Mutations in DGUOK cause mitochondrial DNA depletion syndromes. dGK also phosphorylates several purine deoxyribonucleoside analogs used as therapeutic agents in lymphoproliferative disorders. Overexpression of DGUOK is observed in lung adenocarcinoma and correlated with poor patient survival. Radiolabeled substrates are being explored for imaging T-cell activation using PET tracers targeting dCK/dGK.
Phosphorylation of nucleoside analogs for activation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial Deoxyguanosine Kinase (dGK).